PRISM
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
keywords: IMI projects Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Clinical trial design Disease taxonomy Target identification Drug discovery
- Project website
- http://prism-project.eu/
- Start date
- 2016-04-01
- End date
- 2019-09-30
- Funding
- IMI2 - Call 3 (Grant number 115916)
- Types
- IMI projects